Eli Lilly Soars, Novo Nordisk Plummets On GLP/Obesity Updates - Here's What To Do
Seeking Alpha·2026-02-04 19:26Group 1 - The article emphasizes the importance of understanding key trends and catalysts in the biotech, pharma, and healthcare industries to make informed investment decisions [1] - Edmund Ingham, a biotech consultant, has extensive experience covering over 1,000 companies in the biotech, healthcare, and pharma sectors [1] - The Haggerston BioHealth investing group provides insights for both novice and experienced investors, including product sales forecasts and integrated financial statements [1]